Immunological detection of type II collagen degradation: Use in the evaluation of anti-arthritic therapies

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 7, 1996, Pages 694-698

  Chichester, C O ^a   Barrach, H J ^b   Srinivas, G R ^a   Mitchell, P ^c  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATTLE; CHONDROSARCOMA; COLLAGEN DEGRADATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; EXPLANT; NONHUMAN; NOSE CARTILAGE; RABBIT; RAT;

EID: 0029829957     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03953.x     Document Type: Article

References (22)

1. Andrews, H. J., Plumpton, T. A., Harper, G. P., Cawston, T. E. (1992) A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 37: 147-154
2. Buttle, D. J., Handey, C. J., Ilie, M. Z., Saklatuala, J., Murat, M., Barratt, A. J. (1993) Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and inhibitor of matrix metalloproteases: evidence for two converging pathways of chondrocyte-mediated proleoglycan degradation. Arthritis Rheum. 36: 1709-1717
3. DiPasquale, G., Caccise, R., Pasternak, R., Caputo, C. B., Conaty, J., Hubbs, S. (1986) Lack of response of rat chondrosarcoma chondrocytes to interleukin I to produce proteoglycan and collagen degrading enzymes. Res. Comm. Chem. Pathol. Pharmacol. 52: 333-339
4. Ehrlich, M. G., Houle, P. A., Vigliani, G., Mankin, H. J. (1978) Correlation between articular cartilage collagenase activity and human osteoarthritis. Arthritis Rheum. 24: 761-766
5. Goldberg, R. L., Spirito, S., Doughty, J. R., Ganu, V., Heinegard, D. (1995) Timed dependent release of matrix components from bovine articular cartilage after IL-1 treatment and their inhibition by matrix metalloproteinase inhibitors. Trans. Ortho. Res. Soc. 41: 125
6. Hamerman, D. (1989) The biology of osteoarthritis. N. Eng. J. Med. 320: 1322
7. Henderson, B., Davies, D. E. (1991) The design of inhibitors of cartilage breakdown in osteoarthritis: current research and prospectives for pharmacological intervention. In: Russel, R. G. G., Dieppe, P. A. (eds) Osteoarthritis London: IBC Technical Services, pp 203-215
8. Hinegardner, R. T. (1971) An improved fluorometric assay for DNA. Anal. Biochem. 39: 197-201
9. Hollander, A. P., Heaphfield, T. F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C., Poole, R. (1994) Increased damage to type II collagen in osteoarthritic articular cartilage by new immunoassay. J. Clin Invest. 93: 1722-1732
10. Lohmander, S. L., Hoerrner, L. A., Lark, M. W. (1993) Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 36: 181-189
11. Martel-Pelletier, J., Pelletier, J.-P. (1984) Metalloproteinases: neutral proieases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilages. Arthritis Rheum. 27: 305-312
12. 2 terminal portion of the smaller fragment released from both collagens. Biochemistry 15: 787-792
13. Mohtai, M., Smith, R. L., Schurman, D. J., Tsuji Y., Torti, F., Hutchinson, N., Stetier-Stevenson, W. G., Goldberg, G. I. (1993) Expression of 93-KD type IV collagenase/gelatinase (gelatinase B) in osteoarthritis and its induction in normal human articular cartilage by interleukin 1. J. Clin. Invest. 92: 179-185
14. Nixon, J., Bottomley, K. M., Broadhurst, M. S., Brown, P. A., Johnson, W. A., Lawton, G., Marley, J., Sedwick, A. D., Wilkinson, S. F. (1991) Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro. Int. J. Tissue React. 3: 237-241
15. Pelletier, J.-P., Mineau, F., Faore, M. P., Martel-Pelletier, J. (1990) Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 33: 1466-1476
16. Reich, R., Thompson, E. W., Iwamoto, Y., Martin, G. R., Deason, J. R., Fuller, G. C., Miskin, R. (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 48: 3307
17. Sapolsky, A. I., Keisler, H., Howell, D. S., Woessner, J. F. (1976) Metalloproteases of human articular cartilage that digest cartilage proteoglycans at neutral and acid pH. J. Clin. Invest. 58: 1030-1041
18. Schägger, H., Von Jagow, G. (1987) Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166: 368-379
19. Seed, M., Ismaiel, S., Cheuny, C. Y., Thomson, T. A., Gardner, C. R., Atkins, R. M., Elson, C. J. (1993) Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U2739. Ann. Rheum. Dis. 52: 37-43
20. Srinivas, G. R., Barrach, H.-J., Chichester, C. O.(1993) Quantitative immunoassays for type II collagen and its cyanogen bromide peptides. J. Immunol. Methods 159: 53
21. Srinivas, G. R., Chichester, C. O., Barrach, H.-J., Matoney, A. L. (1994) Effects of antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures. Agents Actions 41: 193-199
22. Vincenti, M. P., Clark, I. M., Brinckerhoff, C. E. (1994) Using inhibitors of metalloproteinases to treat arthritis - easier said than done? Arthritis Rheum. 37: 1115-1126